| Logo | Name | Σ | ||
|---|---|---|---|---|
 | Atos Advancing what matters This account discusses mainly (but not exclusively) the activities of Tech Foundations - the Atos Group business line leading in managed services, focusing on hybrid cloud & infrastructure, employee experience and technology services, through decarbonized, automated and AI-enabled solutions. Eviden designs the scope composed of Atos’ digital, cloud, big data and security business lines. It will be a global leader in data-driven, trusted and sustainable digital transformation. Visit Eviden: https://www.linkedin.com/company/eviden/ and eviden.com Atos is a global leader in digital transformation with 95,000 employees and annual revenue of c. €11 billion. European number one in cybersecurity, cloud and … Tags: CAC40 Sectors: | 1222 | 806 | 312 |
 | Asociación Salud Digital [Automatic translation follows] Join the Digital Transformation of Health We are a non-profit professional association that aims to be a plural meeting place in what refers to Digital Health. Our objective is to share and generate spaces for debate on the use of Information and Communication Technologies (ICT) in the field of Medicine and Health. We also exchange experiences and knowledge with other associations, collaborate with regulatory bodies on the use of ICT in the field of Medicine and health and promote training. digital health and ehealth Sectors: | 46 | 19 | 27 |
 | Roche Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, … Sectors: | 726 | 651 | 17 |
 | Illumina Unlocking the Power of the Genome At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of … Sectors: | 154 | 118 | 9 |
 | Illumina For Startups Illumina for Startups inspires the creation, funding, and growth of genomics and multi-omics startups across the globe. Illumina for Startups Network aims to inspire the creation, funding, and growth of genomics and multi-omics startups across the globe. It is designed for the entrepreneurial ecosystem and focused on building connections, strengthening community, and advancing breakthrough genomics applications. Current Illumina for Startups initiatives include • Startups Grants for founders to work with Illumina sites globally to run proof-of-concept sequencing experiments and • Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina, founded in 2021. https://www.illumina.com/company/illumina-for-startups.html Past initiatives include Illumina Accelerator, company … Sectors: | 524 | 253 | 92 |
 | Amgen #WeareBiotech Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen … Sectors: | 1023 | 616 | 196 |
IT services